Print Page | Contact Us | Sign In | Register
News & Press
Filter news by category:

Read about recent events, essential information and the latest community news.

Displaying page 10 of 10
 |<   <<   <  5  |  6  |  7  |  8  |  9  |  10

Industry News for MS (INforMS)
Wednesday, May 28, 2014   (0 Comments - view/add)
CMSC INforMS: Genzyme Recognizes Sixth Annual World MS Day »
Genzyme Recognizes Sixth Annual World MS Day - Company Supporting Wide Range of Programs to Help Improve the Lives of...
Wednesday, May 28, 2014   (0 Comments - view/add)
CMSC INforMS: EMD Serono Data at CMSC & ACTRIMS Annual Meeting Reinforces Proven Efficacy of Rebif »
EMD Serono Data at CMSC & ACTRIMS Annual Meeting Reinforces Proven Efficacy of Rebif® (interferon beta-1a) and Dem...
Tuesday, May 27, 2014   (0 Comments - view/add)
CMSC INforMS: Acorda Therapeutics to Showcase Online MS Resources at 2014 CMSC/ACTRIMS Meeting »
Acorda Therapeutics to Showcase Online Multiple Sclerosis Resources at 2014 CMSC/ACTRIMS Meeting 05/27/2014 The awa...
Friday, May 23, 2014   (0 Comments - view/add)
CMSC INforMS: CHMP Adopts Positive Opinion for PLEGRIDY as a Treatment for MS in the EU »
CHMP Adopts Positive Opinion for PLEGRIDY™ (Peginterferon Beta-1a) as a Treatment for Multiple Sclerosis in the European U...
Tuesday, May 13, 2014   (0 Comments - view/add)
CMSC INforMS: Opexa Reaches Enrollment Target in PIIb Trial of Personalized Immunotherapy for SPMS »
Opexa Reaches Enrollment Target in Phase IIb Trial of Personalized Immunotherapy for Secondary Progressive Multiple Sclero...
Thursday, May 8, 2014   (0 Comments - view/add)
CMSC INforMS: Teva announces COPAXONE recognized as "Brand of the Year" by Pharm Exec Magazine »
Teva announces COPAXONE® recognized as Brand of the Year by Pharmaceutical Executive Magazine JERUSALEM--(BUSI...
Thursday, May 1, 2014   (0 Comments - view/add)
CMSC INforMS: New TYSABRI Analysis Shows Improved Walking Speed in Significant Number of MS Patients »
New TYSABRI® Analysis at AAN Annual Meeting Shows Improved Walking Speed in Significant Number of MS Patients Thurs...
Wednesday, April 30, 2014   (0 Comments - view/add)
CMSC INforMS: New Data Reinforce Efficacy of TECFIDERA in MS Patients with High Disease Activity »
New Data Reinforce Efficacy of TECFIDERA® (Dimethyl Fumarate) in MS Patients with High Disease Activity Wednesday,...
Wednesday, April 30, 2014   (0 Comments - view/add)
CMSC INforMS: Slowing of Brain Atrophy Sustained at 3 Years in Patients Treated with Lemtrada »
Slowing of Brain Atrophy and Reductions in New Multiple Sclerosis Lesions Sustained at Three Years in Patients Treated wit...
Wednesday, April 30, 2014   (0 Comments - view/add)
CMSC INforMS: Genzyme Announces Multi-Year MS Research Collaboration with Academic Medical Center »
Genzyme Announces Multi-Year Multiple Sclerosis Research Collaboration with Leading Academic Medical Center Wednesday,...
Tuesday, April 29, 2014   (0 Comments - view/add)
CMSC INforMS: Biogen Idec to Present New Two-Year Data from the PLEGRIDY Phase 3 Advance Study »
Biogen Idec to Present New Two-Year Data from the PLEGRIDY™ (Peginterferon Beta-1a) Phase 3 Advance Study at AAN Annual Me...
Saturday, April 19, 2014   (0 Comments - view/add)
CMSC INforMS: Teva Announces Supreme Court Denial of Request for Interim Relief to Stay »
Teva Announces Supreme Court Denial of Request for Interim Relief to Stay Court of Appeals Ruling for Copaxone® Patent...
Monday, April 14, 2014   (0 Comments - view/add)
CMSC INforMS: Biogen Idec to Present New Clinical Data at AAN Annual Meeting »
Biogen Idec to Present New Clinical Data from its Robust Neurology Portfolio at AAN Annual Meeting Monday, April 14, 20...

Displaying page 10 of 10
 |<   <<   <  5  |  6  |  7  |  8  |  9  |  10

The Consortium of Multiple Sclerosis Centers

3 University Plaza Drive, Suite 116 Hackensack, NJ 07601

Tel: 201.487.1050 | Fax: 862.772.7275

info@mscare.org